×

VRX vs. PRGO & SRPT vs the FDA

3:15 PM ET Mon, 25 April 2016

CNBC's Meg Tirrell looks into Valeant Pharma's appointment of Joseph Papa to CEO, as well as Sarepta's showdown with the FDA over a muscular dystrophy drug.